TD Cowen analyst Tara Bancroft initiates coverage on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) with a Buy rating.The analyst comments "Lorundrostat ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE